Poland· PL-100216694
Javlor
A vinflunin product containing vinfluninum, registered in Poland by Pierre Fabre Medicament. The same ATC class is registered in 9 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Vinflunin is registered in 9 of 19 countries.
Countries holding a registration under ATC L01CA05 (vinflunin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Vinflunin · ATC L01CA05
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Vinfluninum
- Manufacturer
- Pierre Fabre Medicament
- Country
- Poland (PL)
- ATC code
- L01CA05
- ATC class
- Vinflunin
- Defined daily dose
- 27.43 mg, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 6
- gtin05909990733217
- gtin05909990733224
- gtin05909990733231
- gtin05909990733248
- gtin05909990733255
- gtin05909990733262
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vinflunin in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- IcelandJavlorPierre Fabre Médicament*
- NorwayJavlorPierre Fabre Medicament
- SwedenJavlor 25 mg/ml Koncentrat till infusionsvätska, lösningPierre Fabre Medicament
- SpainJAVLOR 25 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSIONPierre Fabre Medicament
- United KingdomJavlor 250mg/10ml concentrate for solution for infusion vialsPierre Fabre Ltd
- NetherlandsJavlor 25 mg/ml, Concentraat voor oplossing voor infusiePierre Fabre Medicament
- FranceJAVLOR 25 mg/ml, pour solution à diluer pour perfusionPIERRE FABRE MEDICAMENT
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Javlor
- Liechtenstein · Javlor
- Norway · Javlor
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f569e261-b79c-473e-a7cf-0f4f7c0da2ea GET /v1/drugs/f569e261-b79c-473e-a7cf-0f4f7c0da2ea?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Koncentrat do sporządzania roztworu do infuzji",
"source": "urpl",
"strength": "25 mg/ml",
"packaging": "05909990733217 ¦ Rpz ¦ EU/1/09/550/001 ¦ 53462\n1 fiol. 2 ml\n05909990733224 ¦ Rpz ¦ EU/1/09/550/002 ¦ 53463\n10 fiol. 2 ml\n05909990733231 ¦ Rpz ¦ EU/1/09/550/003 ¦ 53464\n1 fiol. 4 ml\n05909990733248 ¦ Rpz ¦ EU/1/09/550/004 ¦ 53465\n10 fiol. 4 ml\n05909990733255 ¦ Rpz ¦ EU/1/09/550/005 ¦ 53466\n1 fiol. 10 ml\n05909990733262 ¦ Rpz ¦ EU/1/09/550/011 ¦ 53467\n10 fiol. 10 ml\nRpz ¦ EU/1/09/550/009 ¦ 159450\n1 fiol. 4 ml\nRpz ¦ EU/1/09/550/006 ¦ 159451\n10 fiol. 10 ml\nRpz ¦ EU/1/09/550/010 ¦ 159452\n10 fiol. 4 ml\nRpz ¦ EU/1/09/550/012 ¦ 159453\n10 fiol. 10 ml\nRpz ¦ EU/1/09/550/008 ¦ 159454\n10 fiol. 2 ml\nRpz ¦ EU/1/09/550/007 ¦ 159455\n1 fiol. 2 ml",
"substance": "Vinflunine ditartrate 25 mg/ml",
"common_name": "Vinfluninum",
"pl_product_id": "100216694",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about vinflunin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.